EMEA-001015-PIP01-10
Key facts
| Active substance |
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/146/2011
|
| PIP number |
EMEA-001015-PIP01-10
|
| Pharmaceutical form(s) |
Oromucosal drops
|
| Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
| Route(s) of administration |
Sublingual use
|
| Contact for public enquiries |
Lofarma S.p.A.
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|
Decision
-
List item
P/146/2011: EMA decision of 9 June 2011 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for chemically modified house dust mites allergen extract (PDF/147.96 KB)
Adopted
First published: 14/07/2011
Last updated: 14/07/2011
EMA/417760/2011 -
List item
Chemically modified house dust mites allergen extract (dermatophagoides pteronyssinus and dermatophagoides farinae) - Notification of discontinuation of a paediatric development which is covered by an agreed paediatric-investigation-plan decision (PDF/69.98 KB)
First published: 21/04/2021